DJIA 17,689.86 -56.12 -0.32%
NASDAQ 5,128.28 -0.50 -0.01%
S&P 500 2,103.84 -4.79 -0.23%
market minute promo

Novo Nordisk (NYSE: NVO)

58.96 0.68 (1.17%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NVO $58.96 1.17%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $59.33
Previous Close $58.28
Daily Range $58.79 - $59.35
52-Week Range $41.72 - $59.49
Market Cap $156.2B
P/E Ratio 0.00
Dividend (Yield) $0.73 (0.9%)
Ex-Dividend Date
Dividend Pay Date
03/19/15
03/31/15
Volume 1,539,805
Average Daily Volume 1,198,186
Current FY EPS $1.89

Sector

Healthcare

Industry

Drug Makers

Novo Nordisk (NVO) Description

Engaged in discovery, development, manufacturing and marketing of pharmaceutical products and has two business segments - diabetes care and biopharmaceuticals. Website: http://www.novonordisk.com/

News & Commentary Rss Feed

Is This Novo Nordisk's Next Blockbuster Drug?

Novo recently presented terrific data on its pipeline drug IDegLira, but U.S. approval is still far from certain. If it can gain approval, will it be meaningful to the company?

Pre-Market Most Active for Jul 31, 2015 : MFG, NVO, GSK, NOK, CCE, RCL, FEYE, INTC, HOLX, QQQ, GPRO

Pre-Market Most Active for Jul 31, 2015 : MFG, NVO, GSK, NOK, CCE, RCL, FEYE, INTC, HOLX, QQQ, GPRO, XIV

Vivus Reports Q2 Loss- Confirms Obesity Sector Weakness

Top 3 iShares ETFs Provide Exposure To The Health Care Sector

Another Hot BioPharma IPO: vTv Therapeutics

Arena: Sales Flat Again- Belviq Still Losing Market Share

The Weekender

Novo Nordisk A/S (NVO) Hits New Lifetime High

5 NYSE Healthcare Stocks With The Highest ROI

MannKind's Afrezza: An Expensive Failure

Novo Nordisk Up on Positive Results from Diabetes Study - Analyst Blog

See More NVO News...

NVO's Top Competitors

NVO $58.96 (1.17%)
Current stock: NVO
JNJ $100.21 (0.37%)
Current stock: JNJ
NVS $103.75 (0.55%)
Current stock: NVS
RHHBY $36.11 (0.17%)
Current stock: RHHBY